| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |